SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018417
Filing Date
2024-05-09
Accepted
2024-05-09 16:01:52
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 615713
2 ex4-6.htm EX-4.6 60384
3 ex31-1.htm EX-31.1 11483
4 ex31-2.htm EX-31.2 11493
5 ex32-1.htm EX-32.1 8139
6 form10-q_001.jpg GRAPHIC 7800
  Complete submission text file 0001493152-24-018417.txt   3628833

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mtnb-20240331.xsd EX-101.SCH 30947
8 XBRL CALCULATION FILE mtnb-20240331_cal.xml EX-101.CAL 49771
9 XBRL DEFINITION FILE mtnb-20240331_def.xml EX-101.DEF 76183
10 XBRL LABEL FILE mtnb-20240331_lab.xml EX-101.LAB 229314
11 XBRL PRESENTATION FILE mtnb-20240331_pre.xml EX-101.PRE 187808
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 462186
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 24930310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)